Market Research Industry Reports

Sedia Biosciences Corp - Product Pipeline Analysis, 2018 Update

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Sedia Biosciences Corp (SBC) is a medical device company that offers diagnostic products. The company provides medical devices, diagnostic devices, HIV incidence products, rapid point of care assays and specimen collection devices. It offers diagnostic products, epidemiological products, clinical products, rapid point of care diagnostic assays, novel epidemiological disease surveillance assays, monitoring devices and other public health tools. SBC provides services such as technology licensing, commercialization, medical device manufacturing and distributing, diagnostic testing, monitoring, white labeling, and technology transfer and development services. The company markets its products in the US and other European and Asian countries. SBC is headquartered in Portland, Oregon, the US.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Sedia Biosciences Corp
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio



List of Tables 3
List of Figures 3
Sedia Biosciences Corp Company Overview 4
Sedia Biosciences Corp Company Snapshot 4
Sedia Biosciences Corp Pipeline Products and Ongoing Clinical Trials Overview 4
Sedia Biosciences Corp Pipeline Analysis Overview 6
Sedia Biosciences Corp - Key Facts 6
Sedia Biosciences Corp - Major Products and Services 7
Sedia Biosciences Corp Pipeline Products by Development Stage 8
Sedia Biosciences Corp Pipeline Products Overview 10
Asant Rapid Hepatitis B sAg (Hepatitis B Surface Antigen) Blood/Oral Fluid Test 10
Asant Rapid Hepatitis B sAg (Hepatitis B Surface Antigen) Blood/Oral Fluid Test Product Overview 10
Asant Rapid Hepatitis C (Anti-Hepatitis C Antibody) Blood/Oral Fluid Test 11
Asant Rapid Hepatitis C (Anti-Hepatitis C Antibody) Blood/Oral Fluid Test Product Overview 11
Asant Rapid HIV-1 Recency (or Incidence) Assay 12
Asant Rapid HIV-1 Recency (or Incidence) Assay Product Overview 12
Rapid Anti-Hepatitis B Ab Blood/Oral Fluid Test 13
Rapid Anti-Hepatitis B Ab Blood/Oral Fluid Test Product Overview 13
Rapid Oral Fluid HIV Test 14
Rapid Oral Fluid HIV Test Product Overview 14
Rapid Syphilis Oral Fluid Test 15
Rapid Syphilis Oral Fluid Test Product Overview 15
Sedia Biosciences Corp - Key Competitors 16
Sedia Biosciences Corp - Key Employees 17
Sedia Biosciences Corp - Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Sedia Biosciences Corp, Recent Developments 19
Aug 30, 2016: Sedia Biosciences Awarded Additional $1.8 M NIH Grant for Novel Rapid HIV Test for Recent Infections 19
Sep 21, 2015: Sedia Biosciences Expands Its HIV-1 LAg-Avidity Assay for Recent HIV-1 Infections to Dried Blood Spot Specimens 19
Oct 23, 2014: Independent Study Shows Sedias New HIV-1 LAg-Avidity Test is Top Performing Incidence Assay 20
Aug 18, 2014: NIH Awards Sedia Biosciences $195,490 SBIR Grant for Rapid HIV-1 Incidence Assay 20
Aug 13, 2014: Sedia Biosciences Launches Asant DNA, A New DNA Specimen Collection Kit 21
Feb 12, 2014: Sedia Biosciences Receives $1.0 Million NIH Grant for New HIV Diagnostic Assay 21
Appendix 23
Methodology 23
About GlobalData 26
Contact Us 26
Disclaimer 26

List Of Tables

List of Tables
Sedia Biosciences Corp Pipeline Products and Ongoing Clinical Trials Overview 4
Sedia Biosciences Corp Pipeline Products by Equipment Type 5
Sedia Biosciences Corp Pipeline Products by Indication 5
Sedia Biosciences Corp, Key Facts 6
Sedia Biosciences Corp, Major Products and Services 7
Sedia Biosciences Corp Number of Pipeline Products by Development Stage 8
Sedia Biosciences Corp Pipeline Products Summary by Development Stage 9
Asant Rapid Hepatitis B sAg (Hepatitis B Surface Antigen) Blood/Oral Fluid Test - Product Status 10
Asant Rapid Hepatitis B sAg (Hepatitis B Surface Antigen) Blood/Oral Fluid Test - Product Description 10
Asant Rapid Hepatitis C (Anti-Hepatitis C Antibody) Blood/Oral Fluid Test - Product Status 11
Asant Rapid Hepatitis C (Anti-Hepatitis C Antibody) Blood/Oral Fluid Test - Product Description 11
Asant Rapid HIV-1 Recency (or Incidence) Assay - Product Status 12
Asant Rapid HIV-1 Recency (or Incidence) Assay - Product Description 12
Rapid Anti-Hepatitis B Ab Blood/Oral Fluid Test - Product Status 13
Rapid Anti-Hepatitis B Ab Blood/Oral Fluid Test - Product Description 13
Rapid Oral Fluid HIV Test - Product Status 14
Rapid Oral Fluid HIV Test - Product Description 14
Rapid Syphilis Oral Fluid Test - Product Status 15
Rapid Syphilis Oral Fluid Test - Product Description 15
Sedia Biosciences Corp, Key Employees 17
Sedia Biosciences Corp, Subsidiaries 18
Glossary 25

List Of Figures

List of Figures
Sedia Biosciences Corp Pipeline Products by Equipment Type 5
Sedia Biosciences Corp Pipeline Products by Development Stage 8

Sedia Biosciences Corp - Product Pipeline Analysis, 2018 Update

Sedia Biosciences Corp (SBC) is a medical device company that offers diagnostic products. The company provides medical devices, diagnostic devices, HIV incidence products, rapid point of care assays and specimen

USD 750View Report

MUSEDIA CORP Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

MUSEDIA CORP Company Profile is a detailed strategic and analytical report on MUSEDIA CORP. The 2018 version of the report offers detailed insights into the companys strategies, developments, outlook and

USD 200View Report

AmpliPhi Biosciences Corp (APHB) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

AmpliPhi Biosciences Corp (AmpliPhi) is a biotechnology company which focuses on development and commercialization of bacteriophage-based antibacterial therapeutics. The company by utilizing its proprietary bacteriophage technology developed a pipeline of

USD 250View Report

AmpliPhi Biosciences Corporation Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

AmpliPhi Biosciences Corporation Company Profile is a detailed strategic and analytical report on AmpliPhi Biosciences Corporation. The 2018 version of the report offers detailed insights into the companys strategies, developments,

USD 200View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 750
  • Site Licence    USD 1500
  • Enterprise Wide Licence    USD 2250
$ 750

Reports Details

Published Date : Jul 2018
No. of Pages :26
Country :United States of America
Category :Medical Devices
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube